Inactive Instrument
MarketScreener Strategies GlaxoSmithKline plc London S.E.
Stocks
Pharmaceuticals
|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| 08-19 | GSK plc : Deutsche Bank remains Neutral | ZD |
| 08-17 | Chugai grants GSK exclusive global license for AID351 dengue antibody | AN |
MarketScreener Strategies
Search
 | A No to BMS can open doors for a Yes to GSK | August 12, 2026 at 08:55 am |
 | GSK plc: Another beat; we appreciate the new CEO's aggressive intent | July 28, 2026 at 02:23 pm |
 | GSK plc: A beat isn't enough; markets expected an outlook upgrade | April 30, 2026 at 10:57 am |
| GSK plc: Can bet on GSK’s gradually brightening future | March 11, 2026 at 05:47 am |
| GSK plc: Eventually getting into its stride | February 05, 2026 at 09:55 am |
 | GSK: shareholders urge company to step up reinvention | January 20, 2026 at 05:20 am |
| GSK PLC outlook improves amid merger speculation | December 30, 2025 at 01:20 am |
 | MRNA rivals call truce as BioNTech prepares CureVac takeover | August 08, 2025 at 04:30 am |
 | GSK plc : Back on track | May 03, 2024 at 05:16 am |
No results match your criteria
Filters
Headlines
- Stock Market
- Stocks
- GSK Stock
- Stock
- News GlaxoSmithKline plc
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
